|1.||Finke, Jürgen: 5 articles (06/2012 - 02/2003)|
|2.||Bertz, Hartmut: 4 articles (06/2012 - 02/2003)|
|3.||Ikegame, Kazuhiro: 3 articles (12/2012 - 12/2004)|
|4.||Lynch, Maria Isabel: 3 articles (08/2011 - 12/2004)|
|5.||Malagueño, Elizabeth: 3 articles (08/2011 - 12/2004)|
|6.||Ferreira, Silvana: 3 articles (08/2011 - 12/2004)|
|7.||Schmoor, Claudia: 3 articles (06/2011 - 02/2003)|
|8.||Dubey, J P: 3 articles (04/2011 - 10/2002)|
|9.||Neville, David M: 3 articles (03/2008 - 07/2002)|
|10.||Woo, Jung Hee: 3 articles (03/2008 - 07/2002)|
02/01/2000 - "Depletion of gammadelta T cells by anti-T-cell receptor (TCR) gammadelta monoclonal antibody (mAb) treatment resulted in significant increase of virus titre and decrease of IFN-gamma in the liver on day 3 after MCMV infection, which further supports the importance of gammadelta T cells in early protection against infection. "
10/01/2015 - "Considering that Sur drastically reinforced the infection evolution, potentiating the inflammatory process and the severity of cardiac lesions, the in vivo findings contradicted the in vitro anti-T. "
08/01/2015 - "gondii infection was 16.0% (961/6,000), of which 14.5% (870/6,000) were positive for anti-T. "
11/01/2012 - "Congenital infection was confirmed in the presence of persisting anti-T. "
10/01/2012 - "Women who did not undergo a urine test had a 5.3 times higher risk for infection and women who do not have piped water inside their household had a 5.0-fold higher risk of having anti-T. "
10/01/2015 - "The most effective for the diagnosis of toxoplasmosis was SAG2-GRA1-ROP1L, which can detect specific anti-T. "
12/01/2014 - "Analysis was performed using a commercial toxoplasmosis ELISA kit to detect anti-T. "
09/01/2013 - "Diagnosis of toxoplasmosis is mainly based on the results of serological tests detecting anti-T. "
01/01/2010 - "Susceptibility to toxoplasmosis occurred despite upregulation of IFN-γ, TNF-α and NOS2, preservation of IFN-γ-induced microglia/macrophage anti-T. "
02/01/2007 - "The seroprevalence of Toxoplasma gondii infection among pregnant women in the Democratic Republic of Sao Tome and Principe (DRSTP) from November 2003 to March 2004 was determined by detection of serum anti-T. "
01/01/1995 - "T/anti-T assays are highly effective in detecting incipient (TisN0M0 and T1N0M0) carcinomas: DTHR-T-85% of 41, and SPIA-T-96% of 26 patients. "
08/01/1997 - "T/anti-T tests detected preclinical carcinoma in 77% of 48 patients long (mean 6 years) before their biopsy/X-ray results became positive. "
05/01/1992 - "I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody."
01/01/1980 - "An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells."
01/01/1979 - "Patients with breast or G.I. tract carcinoma show statistically significant alteration of anti-T titer levels when compared to patients with benign disease and to healthy controls. "
|4.||Aplastic Anemia (Anemia, Hypoplastic)
06/01/2014 - "The purpose of this study was to investigate the effects of rabbit antihuman thymocyte globulin (R-ATG) and Jurkat cell-reactive anti-T lymphocyte globulin (ATG-F) in the treatment of childhood aplastic anemia (AA) and compare their efficacy and side effects. "
01/01/2015 - "Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice."
06/01/2014 - "Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia."
01/01/2015 - "Immunosuppressive therapy (IST) with anti-T lymphocyte globulin (ATG) plus cyclosporine (CSA) is standard therapy in patients with non-severe aplastic anemia (AA) in need of treatment and severe aplastic anemia (SAA) who do not have an available HLA-matched donor. "
01/01/2011 - "A comparison of Jurkat cell-reactive anti-T lymphocyte globulin and fetal anti-thymocyte globulin preparations in the treatment of aplastic anemia."
|5.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/01/1978 - "A study of surface markers in acute lymphocytic leukemia by using anti-T and anti-B lymphocyte sera."
09/01/1980 - "Four hematopoietic cell lines (CCRF-CEM, HSB-2, MOLT-4, and RPMI-8402), derived from acute lymphoblastic leukemia and expressing T-cell surface markers (T-HCL), were studied with two specific anti-T-cell sera. "
01/01/1984 - "[Transplantation of marrow incubated with anti-T monoclonal antibody in the 4th remission of acute lymphoblastic leukemia from a parent with non-identical HLA]."
03/15/1988 - "Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia."
|2.||Immunoglobulin G (IgG)
|3.||Immunoglobulin M (IgM)
|4.||Adrenal Cortex Hormones (Corticosteroids)
|6.||Antilymphocyte Serum (Anti-Thymocyte Globulin)
|7.||gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)
|9.||Levodopa (L Dopa)
|1.||Transplantation (Transplant Recipients)
|2.||Tissue Therapy (Cell Therapy)
|4.||Homologous Transplantation (Allograft)